Vistagen Therapeutics, Inc. Annual Earnings Per Share, Basic in USD/shares from 2012 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Vistagen Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2012 to 2023.
  • Vistagen Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.42 USD/shares, a 36.4% increase year-over-year.
  • Vistagen Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -0.69 USD/shares, a 85.4% increase year-over-year.
  • Vistagen Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -1.52 USD/shares, a 82.1% increase from 2022.
  • Vistagen Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -8.51 USD/shares, a 15.3% decline from 2021.
  • Vistagen Therapeutics, Inc. annual Earnings Per Share, Basic for 2021 was -7.38 USD/shares, a 1406% decline from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$2 +$6.99 +82.1% Apr 1, 2023 Mar 31, 2024 10-K 2024-06-11
2022 -$9 -$1 -15.3% Apr 1, 2022 Mar 31, 2023 10-K 2024-06-11
2021 -$7 -$7 -1406% Apr 1, 2021 Mar 31, 2022 10-K 2023-06-28
2020 $0 Apr 1, 2020 Mar 31, 2021 10-K 2022-06-23
2015 -$29 -$19 -176% Apr 1, 2015 Mar 31, 2016 10-K 2016-06-24
2014 -$11 -$8 -290% Apr 1, 2014 Mar 31, 2015 10-K 2016-06-24
2013 -$3 -$3 -27100% Apr 1, 2013 Mar 31, 2014 10-K 2015-06-29
2012 $0.01 Apr 1, 2012 Mar 31, 2013 10-Q 2014-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.